カテゴリ： MarketLine, ドイツ, 企業調査

HSH Nordbank AG：企業の戦略・SWOT・財務情報

◆英語タイトル：HSH Nordbank AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11870
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：34
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

HSH Nordbank AG – Strategy, SWOT and Corporate Finance Report
Summary

HSH Nordbank AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

HSH Nordbank AG (HNB), a subsidiary of HSH Beteiligungs Management GmbH, is a provider of financial services. The bank provides corporate finance, long-term project finance, liquidity management and risk management products for utilities, component producers, public transportation authorities, railway operators, sub-suppliers, rolling stock manufacturers, and investors of wind and solar-projects. It also provides real estate financing to project developers, investors and contractors. HNB provides commodities and commodity-derivatives, equity products and equity derivatives, fixed income products and derivatives, funding, FX products and derivatives, securitization, and structured wholesale products to financial institutions, insurance companies, institutional investors, asset managers and other financial institutions. The bank has presence in Germany, Greece, Luxembourg, Hong Kong, Singapore, and the US. HNB is headquartered in Hamburg, Germany.

Scope

- Detailed information on HSH Nordbank AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting HSH Nordbank AG in the form of a SWOT analysis
- An in-depth view of the business model of HSH Nordbank AG including a breakdown and examination of key business segments
- Intelligence on HSH Nordbank AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about HSH Nordbank AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of HSH Nordbank AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess HSH Nordbank AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on HSH Nordbank AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
HSH Nordbank AG: Company Overview 9
HSH Nordbank AG: Overview and Key Facts 9
HSH Nordbank AG: Overview 9
HSH Nordbank AG: Key Facts 9
HSH Nordbank AG: Key Employees 10
HSH Nordbank AG: Key Employee Biographies 11
HSH Nordbank AG: Major Products and Services 12
HSH Nordbank AG: Company History 13
HSH Nordbank AG: Management Statement 15
HSH Nordbank AG: Locations and Subsidiaries 16
HSH Nordbank AG: Key Competitors 18
HSH Nordbank AG: Company Analysis 19
HSH Nordbank AG: Business Description 19
HSH Nordbank AG: SWOT Analysis 20
HSH Nordbank AG: SWOT Overview 20
HSH Nordbank AG: Strengths 20
HSH Nordbank AG: Weaknesses 21
HSH Nordbank AG: Opportunities 21
HSH Nordbank AG: Threats 21
HSH Nordbank AG: Corporate Financial Deals Activity 23
HSH Nordbank AG: Financial Deals Overview 23
HSH Nordbank AG: Top Deals 2014 – 2018YTD* 25
HSH Nordbank AG: Advisors 26
HSH Nordbank AG: Top Legal Advisors 26
HSH Nordbank AG: Capital Raising 27
HSH Nordbank AG: Divestments 28
HSH Nordbank AG: Private Equity and Ownership 29
HSH Nordbank AG: Recent Developments 30
HSH Nordbank AG: News and Events Summary 30
HSH Nordbank AG: Financial Deals 30
HSH Nordbank AG: Financial Performance 31
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: HSH Nordbank AG: Key Facts
Table 2: HSH Nordbank AG: Key Employees
Table 3: HSH Nordbank AG: Company History
Table 4: HSH Nordbank AG: Locations and Subsidiaries
Table 5: HSH Nordbank AG: Key Competitors
Table 6: HSH Nordbank AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: HSH Nordbank AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: HSH Nordbank AG: Top Deals 2014 - 2018YTD*
Table 9: HSH Nordbank AG: Legal Advisor Ranking by Value (US$m)
Table 10: HSH Nordbank AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: HSH Nordbank AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: HSH Nordbank AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: HSH Nordbank AG: Divestments by Geography (2014 - YTD*2018)
Table 14: HSH Nordbank AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 15: HSH Nordbank AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 16: HSH Nordbank AG: News and Events Summary
Table 17: HSH Nordbank AG: Financial Deals
Table 18: HSH Nordbank AG: Financial Performance

List of Figures
Figure 1: HSH Nordbank AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: HSH Nordbank AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: HSH Nordbank AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: HSH Nordbank AG: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: HSH Nordbank AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: HSH Nordbank AG: Divestments by Geography (2014 - YTD*2018)
Figure 7: HSH Nordbank AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 8: HSH Nordbank AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[HSH Nordbank AG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Berry Global Group, Inc.：企業の戦略・SWOT・財務情報
    Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • East Kentucky Power Cooperative Inc：企業の戦略的SWOT分析
    East Kentucky Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • M1 Ltd：企業の戦略的SWOT分析
    M1 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Censa Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Censa Pharmaceuticals Inc (Censa Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for the treatment of rare central nervous system (CNS) disorders. The company provides product pipeline such as therapies for the treatment of extremely rare disorders …
  • Dolby Laboratories Inc (DLB)：企業の財務・戦略的SWOT分析
    Dolby Laboratories Inc (DLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • TBG Diagnostics Ltd (TDL)-医療機器分野：企業M&A・提携分析
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical researc …
  • Hydro One Ltd (H)：企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Organo Corporation：企業の戦略・SWOT・財務情報
    Organo Corporation - Strategy, SWOT and Corporate Finance Report Summary Organo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cedar Fair, L.P.：企業の戦略・SWOT・財務情報
    Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report Summary Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Charter Communications, Inc.：戦略・SWOT・企業財務分析
    Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BNP Paribas SA：企業の戦略・SWOT・財務情報
    BNP Paribas SA - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Catholic United Financial：企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • VolitionRX Ltd (VNRX)：医療機器：M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • ManTech International Corp (MANT)：企業の財務・戦略的SWOT分析
    ManTech International Corp (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • American Bio Medica Corp (ABMC)：企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Premaitha Health Plc (NIPT)-製薬・医療分野：企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Atara Biotherapeutics Inc (ATRA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • PACCAR Inc (PCAR)：企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bentley Systems Incorporated：企業のM&A・事業提携・投資動向
    Bentley Systems Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bentley Systems Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • OptiNose US Inc (OPTN)：製薬・医療：M&Aディール及び事業提携情報
    Summary OptiNose US Inc (OptiNose) is a specialty pharmaceutical company that develops and delivers new pipeline drugs through intranasal deposition of medications. The company offers products such as XHANCE fluticasone propionate and ONZETRA sumatriptan nasal powder. Its products are used in the th …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆